Morgan Stanley Kazia Therapeutics LTD Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Kazia Therapeutics LTD stock. As of the latest transaction made, Morgan Stanley holds 220,261 shares of KZIA stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
220,261
Previous 201,082
9.54%
Holding current value
$1.24 Million
Previous $46,000
104.35%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding KZIA
# of Institutions
21Shares Held
2.13MCall Options Held
93.2KPut Options Held
0-
Mai Capital Management1.36MShares$7.65 Million0.01% of portfolio
-
Ubs Group Ag249KShares$1.4 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il60.5KShares$339,2700.0% of portfolio
-
Jane Street Group, LLC New York, NY46.1KShares$258,6770.0% of portfolio
-
United Bank Vienna, VA44KShares$246,8400.0% of portfolio
About KAZIA THERAPEUTICS LTD
- Ticker KZIA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,111,300
- Market Cap $84.8M
- Description
- Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...